Literature DB >> 16610971

Warfarin and its interactions with foods, herbs and other dietary supplements.

Edith A Nutescu1, Nancy L Shapiro, Sonia Ibrahim, Patricia West.   

Abstract

Despite its complex pharmacokinetic and pharmacodynamic profile, warfarin is still one of the most widely used oral anticoagulant agents. Attaining optimal anticoagulation with this agent is clinically challenging in view of its many food and drug interactions. Inappropriate anticoagulation control can expose patients to an increased risk of bleeding or thromboembolic complications, due to over and underanticoagulation, respectively. Fluctuations in dietary vitamin K intake can have a significant effect on the degree of anticoagulation in patients treated with warfarin. In addition, the explosion in use of various dietary supplements and herbal products can lead to undesired outcomes on anticoagulant levels. The aim of this review is to discuss the scope and the potential clinical impact of the most commonly reported food, dietary supplement and herbal interactions with warfarin therapy. Practical steps for patients and providers to minimise these interactions are highlighted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610971     DOI: 10.1517/14740338.5.3.433

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  40 in total

Review 1.  Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Walter Ageno; Alexander S Gallus; Ann Wittkowsky; Mark Crowther; Elaine M Hylek; Gualtiero Palareti
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Telephone versus office-based management of warfarin: impact on international normalized ratios and outcomes.

Authors:  Laura G Stoudenmire; Christina E DeRemer; Hazem Elewa
Journal:  Int J Hematol       Date:  2014-06-21       Impact factor: 2.490

3.  Venous thromboembolic disease.

Authors:  Michael B Streiff; Paula L Bockenstedt; Spero R Cataland; Carolyn Chesney; Charles Eby; John Fanikos; Patrick F Fogarty; Shuwei Gao; Julio Garcia-Aguilar; Samuel Z Goldhaber; Hani Hassoun; Paul Hendrie; Bjorn Holmstrom; Kimberly A Jones; Nicole Kuderer; Jason T Lee; Michael M Millenson; Anne T Neff; Thomas L Ortel; Judy L Smith; Gary C Yee; Anaadriana Zakarija
Journal:  J Natl Compr Canc Netw       Date:  2011-07-01       Impact factor: 11.908

Review 4.  Interaction between warfarin and Chinese herbal medicines.

Authors:  Yan Ting Chua; Xiang Ling Ang; Xi Ming Zhong; Kei Siong Khoo
Journal:  Singapore Med J       Date:  2015-01       Impact factor: 1.858

5.  New educational approach for patients on warfarin improves knowledge and therapy control.

Authors:  Alenka Mavri; Nina Ostasevski Fernandez; Anja Kramaric; Katarina Kosmelj
Journal:  Wien Klin Wochenschr       Date:  2015-04-01       Impact factor: 1.704

Review 6.  Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice.

Authors:  Alberto Corsini; Nicola Ferri; Marco Proietti; Giuseppe Boriani
Journal:  Drugs       Date:  2020-07       Impact factor: 9.546

7.  Trends in oral anticoagulant use in Qatar: a 5-year experience.

Authors:  Hazem Elewa; Amani Alhaddad; Safa Al-Rawi; Amir Nounou; Hesham Mahmoud; Rajvir Singh
Journal:  J Thromb Thrombolysis       Date:  2017-04       Impact factor: 2.300

Review 8.  Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.

Authors:  Edith Nutescu; Ittiporn Chuatrisorn; Erika Hellenbart
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

9.  Interaction between warfarin and astaxanthin: A case report.

Authors:  Naiyana Santiyanon; Suwimon Yeephu
Journal:  J Cardiol Cases       Date:  2019-02-18

10.  The warfarin-cranberry juice interaction revisited: A systematic in vitro-in vivo evaluation.

Authors:  Ngoc Ngo; Scott J Brantley; Daniel R Carrizosa; Angela Dm Kashuba; E Claire Dees; David J Kroll; Nicholas H Oberlies; Mary F Paine
Journal:  J Exp Pharmacol       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.